ArticleThe Journal of clinical investigation2024

STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma.

Hinda Najem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.